Literature DB >> 11565806

Molecular mechanism to maintain stem cell renewal of ES cells.

H Niwa1.   

Abstract

Embryonic stem (ES) cells are pluripotent cells directly derived from early stage embryos that retain the ability to differentiate into all cell types. This unique feature is the basis of various applications of ES cell technology such as in vitro models of mammalian development, germline transgenesis to make knockout mice, and a generic source for cell therapy in regenerative medicine. To achieve success in these applications, the pluripotency of ES cells has to be kept stable during long-term culture in vitro, leading to the necessity of determining the molecular basis for maintaining ES self-renewal. This paper summarizes the recent progress in this area, focusing mainly on the LIF signaling pathway and the transcription factor Oct-3/4. Although it is still unclear how these components works together, a model is presented here that provides a plan to solve this problem.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11565806     DOI: 10.1247/csf.26.137

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  63 in total

1.  Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.

Authors:  Hitoshi Niwa; Shinji Masui; Ian Chambers; Austin G Smith; Jun-ichi Miyazaki
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity.

Authors:  Tetsuya S Tanaka; Tilo Kunath; Wendy L Kimber; Saied A Jaradat; Carole A Stagg; Masayuki Usuda; Takashi Yokota; Hitoshi Niwa; Janet Rossant; Minoru S H Ko
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

Review 3.  The topographical regulation of embryonic stem cell differentiation.

Authors:  Patricia Murray; David Edgar
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

4.  Transcription factor cCP2 controls gene expression in chicken embryonic stem cells.

Authors:  Hervé Acloque; Anne Mey; Anne Marie Birot; Henri Gruffat; Bertrand Pain; Jacques Samarut
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

5.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

6.  Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation.

Authors:  Peili Gu; Damien LeMenuet; Arthur C-K Chung; Michael Mancini; David A Wheeler; Austin J Cooney
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

Review 7.  Amnion-derived pluripotent/multipotent stem cells.

Authors:  Toshio Miki; Stephen C Strom
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

8.  Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue.

Authors:  Reza Izadpanah; Cynthia Trygg; Bindiya Patel; Christopher Kriedt; Jason Dufour; Jeffery M Gimble; Bruce A Bunnell
Journal:  J Cell Biochem       Date:  2006-12-01       Impact factor: 4.429

9.  Self-renewal and differentiation of mouse embryonic stem cells as measured by Oct4 expression: the role of the cAMP/PKA pathway.

Authors:  S Faherty; A Fitzgerald; M Keohan; L R Quinlan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-01       Impact factor: 2.416

Review 10.  Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells.

Authors:  Angie Rizzino
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.